ABIVAX SA (2X1.DE) Forecast, Price Target & Analyst Ratings

FRA:2X1 • FR0012333284

Current stock price

107.9 EUR
+3.3 (+3.15%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ABIVAX SA (2X1.DE).

Forecast Snapshot

Consensus Price Target

Price Target
€127.76
+ 18.40% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 25, 2026
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
85.71%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
€127.76
Upside
+ 18.40%
From current price of €107.90 to mean target of €127.76, Based on 14 analyst forecasts
Low
€63.38
Median
€136.14
High
€177.79

Price Target Revisions

1 Month
-0.21%
3 Months
11.94%

Price Target Summary

14 Wall Street analysts provided a forecast for the next 12 months for 2X1.DE. The average price target is 127.76 EUR. This implies a price increase of 18.4% is expected in the next year compared to the current price of 107.9.
The average price target has been revised upward by 11.94% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

2X1 Current Analyst Rating2X1 Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5

Analyst Ratings History

2X1 Historical Analyst Ratings2X1 Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -18 -16 -14 -12 -10 -8 -6 -4 -2 0 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
85.71%
2X1.DE was analyzed by 14 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about 2X1.DE.
In the previous month the buy percentage consensus was at a similar level.
2X1.DE was analyzed by 14 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 25, 2026

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
2X1.DE revenue by date.2X1.DE revenue by date.
N/AN/A
3,694.18%		N/A
288.43%		N/A
-22.66%		N/A
52.13%		N/A
29.34%		N/A
42.23%		N/A
15.91%
EBITDA
YoY % growth
2X1.DE ebitda by date.2X1.DE ebitda by date.
-18.119MN/A
66.28%		-14.057M
-130.05%		-19.037M
-35.43%		-33.216M
-74.48%		-37.942M
-14.23%		-42.404M
-11.76%		-50.719M
-19.61%		-126.669M
-149.75%		-171.884M
-35.70%		N/A
-25.11%		N/A
-10.20%		N/A
71.55%		N/A
1,003.86%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
2X1.DE ebit by date.2X1.DE ebit by date.
-18.255M-18.236M
0.10%		-14.15M
22.41%		-19.108M
-35.04%		-33.296M
-74.25%		-38.008M
-14.15%		-42.56M
-11.98%		-51.204M
-20.31%		-127.376M
-148.76%		-172.984M
-35.81%		-246.1M
-42.27%		N/A
9.38%		N/A
52.40%		N/A
184.62%		N/A
301.34%		N/A
102.11%		N/A
51.79%		N/A
61.39%		N/A
18.10%
Operating Margin
2X1.DE operating margin by date.2X1.DE operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
2X1.DE eps by date.2X1.DE eps by date.
N/AN/A
81.03%		N/A
-178.79%		N/A
-88.59%		N/A
-32.95%		N/A
-11.97%		N/A
173.61%		N/A
-259.69%		N/A
19.63%		N/A
-6.86%		N/A
-20.70%		N/A
81.52%		N/A
-363.61%		N/A
88.50%		N/A
-1,141.39%		N/A
26.18%		N/A
83.69%		N/AN/A

All data in EUR

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in EUR

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

2X1.DE Yearly Revenue VS Estimates2X1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B 2B 2.5B
2X1.DE Yearly EPS VS Estimates2X1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 1 -1 -2 -3

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
23.89%
EPS Next 5 Year
1.87%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
428.60%
Revenue Next 5 Year
180.54%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
69.97%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ABIVAX SA / 2X1.DE Forecast FAQ

What is the average price target for ABIVAX SA (2X1.DE) stock?

14 analysts have analysed 2X1.DE and the average price target is 127.76 EUR. This implies a price increase of 18.4% is expected in the next year compared to the current price of 107.9.

What is the next earnings date for 2X1 stock?

ABIVAX SA (2X1.DE) will report earnings on 2026-05-25.

What is the number of analysts for 2X1 stock?

The number of analysts covering ABIVAX SA (2X1.DE) is 14.